Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Anoikis in cancer: the role of lipid signaling
Malignantly transformed cells must alter their metabolic status to stay viable in a harsh
microenvironment and maintain their ability to invade and spread. Anoikis, a specific …
microenvironment and maintain their ability to invade and spread. Anoikis, a specific …
Nobiletin as a chemopreventive natural product against cancer, a comprehensive review
YY Chen, JJ Liang, DL Wang, JB Chen… - Critical Reviews in …, 2023 - Taylor & Francis
As a leading cause of death, second only to heart disease, cancer has always been one of
the burning topics in medical research. When targeting multiple signal pathways in …
the burning topics in medical research. When targeting multiple signal pathways in …
[HTML][HTML] Cold atmospheric plasma is a potent tool to improve chemotherapy in melanoma in vitro and in vivo
Malignant melanoma is a devastating disease. Because of its aggressiveness, it also serves
as a model tumor for investigating novel therapeutic avenues. In recent years, scientific …
as a model tumor for investigating novel therapeutic avenues. In recent years, scientific …
MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells
N Mukherjee, J Skees, KJ Todd, DA West… - Cell death & …, 2020 - nature.com
Current treatment for patients with metastatic melanoma include molecular-targeted
therapies and immune checkpoint inhibitors. However, a subset of melanomas are difficult-to …
therapies and immune checkpoint inhibitors. However, a subset of melanomas are difficult-to …
Medical Gas Plasma Technology Combines with Antimelanoma Therapies and Promotes Immune‐Checkpoint Therapy Responses
Strategies to improve activity and selectivity are major goals in oncological drug
development. Medical gas plasma therapy has been subject to intense research in …
development. Medical gas plasma therapy has been subject to intense research in …
[HTML][HTML] Diosmetin inhibits tumor development and block tumor angiogenesis in skin cancer
J Choi, DH Lee, SY Park, JW Seol - Biomedicine & Pharmacotherapy, 2019 - Elsevier
Diosmetin is a natural flavonoid obtained from citrus fruits and some medicinal herbs.
Previous studies have reported the anti-cancer activity of diosmetin in some types of tumors …
Previous studies have reported the anti-cancer activity of diosmetin in some types of tumors …
[HTML][HTML] Pro-survival role of MITF in melanoma
ML Hartman, M Czyz - Journal of Investigative Dermatology, 2015 - Elsevier
Melanoma is a therapy-resistant skin cancer due to numerous mechanisms supporting cell
survival. Although components of melanoma cytoprotective mechanisms are overexpressed …
survival. Although components of melanoma cytoprotective mechanisms are overexpressed …
Targeted tumor therapy remixed—an update on the use of small-molecule drugs in combination therapies
MV Gatzka - Cancers, 2018 - mdpi.com
Over the last decade, the treatment of tumor patients has been revolutionized by the highly
successful introduction of novel targeted therapies, in particular small-molecule kinase …
successful introduction of novel targeted therapies, in particular small-molecule kinase …
[HTML][HTML] Countering TRAIL resistance in melanoma
J Eberle - Cancers, 2019 - mdpi.com
Melanoma of the skin has become a prime example for demonstrating the success of
targeted cancer therapy. Nevertheless, high mortality has remained, mainly related to tumor …
targeted cancer therapy. Nevertheless, high mortality has remained, mainly related to tumor …
[HTML][HTML] Cell cycle phase-specific drug resistance as an escape mechanism of melanoma cells
KA Beaumont, DS Hill, SM Daignault, GYL Lui… - Journal of Investigative …, 2016 - Elsevier
The tumor microenvironment is characterized by cancer cell subpopulations with
heterogeneous cell cycle profiles. For example, hypoxic tumor zones contain clusters of …
heterogeneous cell cycle profiles. For example, hypoxic tumor zones contain clusters of …